Free Trial
NASDAQ:LIPO

Lipella Pharmaceuticals (LIPO) Stock Price, News & Analysis

Lipella Pharmaceuticals logo
$0.56 -0.04 (-6.07%)
As of 08/8/2025 01:17 PM Eastern

About Lipella Pharmaceuticals Stock (NASDAQ:LIPO)

Key Stats

Today's Range
$0.55
$0.60
50-Day Range
$0.57
$3.09
52-Week Range
$0.55
$7.31
Volume
5,644 shs
Average Volume
937,882 shs
Market Capitalization
$2.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lipella Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

LIPO MarketRank™: 

Lipella Pharmaceuticals scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Lipella Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Lipella Pharmaceuticals is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Lipella Pharmaceuticals is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Lipella Pharmaceuticals has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Lipella Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    0.06% of the outstanding shares of Lipella Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    Lipella Pharmaceuticals has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Lipella Pharmaceuticals has recently decreased by 65.06%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Lipella Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Lipella Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.06% of the outstanding shares of Lipella Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    Lipella Pharmaceuticals has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Lipella Pharmaceuticals has recently decreased by 65.06%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 1 people have searched for LIPO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Lipella Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    32.11% of the stock of Lipella Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    74.31% of the stock of Lipella Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Lipella Pharmaceuticals' insider trading history.
Receive LIPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

LIPO Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.
See More Headlines

LIPO Stock Analysis - Frequently Asked Questions

Lipella Pharmaceuticals' stock was trading at $3.05 at the start of the year. Since then, LIPO shares have decreased by 81.5% and is now trading at $0.5650.

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.64) EPS for the quarter. The firm had revenue of $0.13 million for the quarter. Lipella Pharmaceuticals had a negative trailing twelve-month return on equity of 224.08% and a negative net margin of 988.83%.

Lipella Pharmaceuticals shares reverse split before market open on Friday, November 8th 2024.A 1-8 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Lipella Pharmaceuticals (LIPO) raised $7 million in an initial public offering (IPO) on Tuesday, December 20th 2022. The company issued 1,217,391 shares at $5.75 per share.

Shares of LIPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lipella Pharmaceuticals investors own include Sangamo Therapeutics (SGMO), MSP Recovery (LIFW), NVIDIA (NVDA), Heatwurx (PCSA), Energy Transfer (ET), Labor Smart (LTNC) and NIO (NIO).

Company Calendar

Last Earnings
5/14/2025
Today
8/08/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LIPO
CIK
1347242
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.02 million
Net Margins
-988.83%
Pretax Margin
-988.63%
Return on Equity
-224.08%
Return on Assets
-172.88%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.21
Quick Ratio
6.21

Sales & Book Value

Annual Sales
$536.36 thousand
Price / Sales
4.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.59 per share
Price / Book
0.36

Miscellaneous

Outstanding Shares
4,467,000
Free Float
3,033,000
Market Cap
$2.52 million
Optionable
Not Optionable
Beta
-0.10

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:LIPO) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners